MGIM
ALXN

M&G Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

M&G Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-43,941
Closed -$8.09K – 808
2021
Q2 		$8.09K Buy
+43,941
New +$7.54M 0.02% 296
2021
Q1 		– Sell
-37,887
Closed -$5.91K – 495
2020
Q4 		$5.91K Sell
37,887
-7,823
-17% -$1.01M 0.04% 219
2020
Q3 		$5.21M Sell
45,710
-2,494
-5% -$269K 0.05% 219
2020
Q2 		$5.4M Buy
48,204
+29,406
+156% +$3.12M 0.06% 210
2020
Q1 		$1.69M Hold
18,798
– – 0.02% 256
2019
Q4 		$2.03M Buy
+18,798
New +$2.01M 0.02% 270

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

M&G Investment Management's ALXN Position: Q3 2021 in Review

M&G Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 43,941 shares — an estimated $8.09K sold.

M&G Investment Management first reported a position in ALXN in Q4 2019 and held it in 6 quarters. The position peaked at $5.4M in Q2 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • M&G Investment Management reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • M&G Investment Management sold 43,941 Alexion Pharmaceuticals shares in Q3 2021, an estimated $8.09K.
  • M&G Investment Management first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 6 quarters.
  • M&G Investment Management's Alexion Pharmaceuticals position peaked at $5.4M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on M&G Investment Management's 13F filing for Q3 2021, filed 9 Nov 2021.